Xinghao Wang

机构：University of Michigan · ORCID：0000-0001-8264-8537

发表论文 48 篇 · 总被引 3151 次 · h-index 23

代表论文

• Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus (2021 · Nature Communications · 被引 200)
• Structure and dynamics of the EGFR/HER2 heterodimer (2023 · Cell Discovery · 被引 147)
• Neutrophil extracellular trap-associated carbamylation and histones trigger osteoclast formation in rheumatoid arthritis (2023 · Annals of the Rheumatic Diseases · 被引 130)
• Modulation of the Itaconate Pathway Attenuates Murine Lupus (2022 · Arthritis & Rheumatology · 被引 45)
• Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus (2022 · Annals of the Rheumatic Diseases · 被引 25)
• Chiral multi-curved shell metamaterials integrating compression-torsion and buckling mechanisms for ideal energy absorption (2025 · Nature Communications · 被引 16)